Cargando…
Fenofibrate reduces osteonecrosis without affecting antileukemic efficacy in dexamethasone-treated mice
Recent clinical trials in children with acute lymphoblastic leukemia (ALL) indicate that severe hypertriglyceridemia (>1000 mg/dL) during therapy is associated with an increased frequency of symptomatic osteonecrosis. Interventions to lower triglycerides have been considered, but there have been...
Autores principales: | Finch, Emily R., Payton, Monique A., Jenkins, David A., Cai, Xiangjun, Li, Lie, Karol, Seth E., Relling, Mary V., Janke, Laura J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Fondazione Ferrata Storti
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8327737/ https://www.ncbi.nlm.nih.gov/pubmed/32675219 http://dx.doi.org/10.3324/haematol.2020.252767 |
Ejemplares similares
-
Asparaginase combined with discontinuous dexamethasone improves antileukemic efficacy without increasing osteonecrosis in preclinical models
por: Karol, Seth E., et al.
Publicado: (2019) -
Antileukemic Efficacy of Continuous vs Discontinuous Dexamethasone in Murine Models of Acute Lymphoblastic Leukemia
por: Ramsey, Laura B., et al.
Publicado: (2015) -
Asparaginase Potentiates Glucocorticoid-Induced Osteonecrosis in a Mouse Model
por: Liu, Chengcheng, et al.
Publicado: (2016) -
Antileukemic activity of novel adenosine derivatives
por: Poczta, Anastazja, et al.
Publicado: (2019) -
A Review of Currently Available Fenofibrate and Fenofibric Acid Formulations
por: Ling, Hua, et al.
Publicado: (2013)